Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in BMJ Retrieve available abstracts of 47 articles: HTML format

Single Articles

September 2025
1. ZHANG J, Liu X, Xu Y
   Cardiovascular toxicity risks in treating EGFR-mutated lung cancer.
   BMJ. 2025;390:r1834.
   PubMed    
   
   
   
2. MA Z, Cao F, Liao M, Min R, et al
   Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
   BMJ. 2025;390:e082834.
   PubMed     Abstract available
   
   
   
3. BOWIE K
   Clopidogrel better than aspirin for preventing heart attack and stroke in patients with coronary artery disease, study finds.
   BMJ. 2025;390:r1844.
   PubMed    
   
   
   August 2025
4. AGARWAL A, Mustafa R, Manja V, Agoritsas T, et al
   Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
   BMJ. 2025;390:e082071.
   PubMed     Abstract available
   
   
   July 2025
5. PICCOLO R, Laino A, Vitale AP, Franzone A, et al
   Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis.
   BMJ. 2025;390:e082974.
   PubMed     Abstract available
   
   
   
6. TAYAL U
   Sex differences in antithrombotic therapy for coronary artery disease.
   BMJ. 2025;390:r1560.
   PubMed    
   
   
   June 2025
7. GIACOPPO D, Gragnano F, Watanabe H, Kimura T, et al
   P2Y(12) inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.
   BMJ. 2025;389:e082561.
   PubMed     Abstract available
   
   
   
8. REDDY RK, Bansal R, Ardissino M
   Antiplatelet monotherapy after percutaneous coronary intervention.
   BMJ. 2025;389:r1089.
   PubMed    
   
   
   May 2025
9. ZHANG X, Wang S, Zhou X, Tang Y, et al
   A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial.
   BMJ. 2025;389:e082765.
   PubMed     Abstract available
   
   
   
10. JANSEN C, van der Palen J, Tabak M
    Using mobile health to reduce cardiovascular disease risk.
    BMJ. 2025;389:r972.
    PubMed    
    
    
    
11. BORLAND S
    Why are UK cardiovascular deaths in under 65s rising again?
    BMJ. 2025;389:r1015.
    PubMed    
    
    
    
12. 
    Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2025;389:r863.
    PubMed    
    
    
    
13. 
    Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2025;389:r859.
    PubMed    
    
    
    April 2025
14. JIANG H
    No-touch vein harvesting in coronary artery bypass surgery.
    BMJ. 2025;389:r728.
    PubMed    
    
    
    
15. TIAN M, Wang X, Feng W, Wang H, et al
    No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
    BMJ. 2025;389:e082883.
    PubMed     Abstract available
    
    
    March 2025
16. GAO C, Zhu B, Ouyang F, Wen S, et al
    Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial.
    BMJ. 2025;388:e082945.
    PubMed     Abstract available
    
    
    
17. BELLOLIO F, Gottlieb M, Body R, Than MP, et al
    Evaluating patients with chest pain in the emergency department.
    BMJ. 2025;388:r136.
    PubMed     Abstract available
    
    
    
18. HAN J, Zhai W, Wu Z, Zhang Z, et al
    Care guided by tissue oxygenation and haemodynamic monitoring in off-pump coronary artery bypass grafting (Bottomline-CS): assessor blind, single centre, randomised controlled trial.
    BMJ. 2025;388:e082104.
    PubMed     Abstract available
    
    
    February 2025
19. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
    Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
    BMJ. 2025;388:e082801.
    PubMed     Abstract available
    
    
    
20. WISE J
    Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports.
    BMJ. 2025;388:r287.
    PubMed    
    
    
    January 2025
21. HU W, Tao C, Wang L, Chen Z, et al
    Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial.
    BMJ. 2025;388:e080489.
    PubMed     Abstract available
    
    
    November 2024
22. JOHANSSON T, Karlsson T, Bliuc D, Schmitz D, et al
    Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial.
    BMJ. 2024;387:e078784.
    PubMed     Abstract available
    
    
    
23. MAHASE E
    Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds.
    BMJ. 2024;387:q2518.
    PubMed    
    
    
    October 2024
24. 
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;387:q2381.
    PubMed    
    
    
    
25. LU J, Xu Y, Bi Y, Wang T, et al
    Reducing inequity through tackling social determinants of cardiovascular diseases in China.
    BMJ. 2024;387:e079197.
    PubMed    
    
    
    September 2024
26. INOUE K, Athey S, Baicker K, Tsugawa Y, et al
    Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2024;386:e079377.
    PubMed     Abstract available
    
    
    
27. YANG C, Tebbutt SJ
    Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2024;386:q1807.
    PubMed     Abstract available
    
    
    August 2024
28. MENG R, Wang W, Huang T, Zhan S, et al
    Tackling social and behavioural risk factors for cardiovascular diseases in Chinese women.
    BMJ. 2024;386:e078638.
    PubMed    
    
    
    
29. MAHASE E
    Incidence of cardiovascular events was lower after covid-19 vaccination, study finds.
    BMJ. 2024;386:q1732.
    PubMed    
    
    
    July 2024
30. IACOBUCCI G
    Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
    BMJ. 2024;386:q1660.
    PubMed    
    
    
    June 2024
31. 
    Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
    BMJ. 2024;385:q1450.
    PubMed    
    
    
    
32. CONRAD N, Molenberghs G, Verbeke G, Zaccardi F, et al
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;385:e078523.
    PubMed     Abstract available
    
    
    
33. ZHU Y, Zhang W, Dimagli A, Han L, et al
    Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    BMJ. 2024;385:e075707.
    PubMed     Abstract available
    
    
    
34. SANDNER S
    Dual antiplatelet therapy after coronary artery bypass surgery.
    BMJ. 2024;385:q1083.
    PubMed    
    
    
    
35. 
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1237.
    PubMed    
    
    
    May 2024
36. DYER C
    Former cardiovascular surgery lead is charged with 14 counts of sexual assault.
    BMJ. 2024;385:q1188.
    PubMed    
    
    
    
37. 
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:q1197.
    PubMed    
    
    
    
38. 
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1094.
    PubMed    
    
    
    
39. PALASKAS NL, Ali HJ, Koutroumpakis E, Ganatra S, et al
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:e075859.
    PubMed     Abstract available
    
    
    
40. LI Z, Min XW, He PG, Zhang CH, et al
    Chest pain with diffuse ST segment elevation.
    BMJ. 2024;385:e078403.
    PubMed    
    
    
    April 2024
41. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    PubMed     Abstract available
    
    
    
42. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
    Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
    BMJ. 2024;385:e076268.
    PubMed     Abstract available
    
    
    
43. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
    Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
    BMJ. 2024;385:e077209.
    PubMed     Abstract available
    
    
    March 2024
44. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
    Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
    BMJ. 2024;384:q637.
    PubMed    
    
    
    
45. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    PubMed     Abstract available
    
    
    
46. TANNE JH
    Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
    BMJ. 2024;384:q642.
    PubMed    
    
    
    February 2024
47. 
    Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:q517.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.